ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., April 16, 2025 (GLOBE NEWSWIRE) -- Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a ...

The test, utilising next-generation sequencing and machine learning, measures the functions of oral microbial cells in each ...

The global nuclear magnetic resonance (NMR) spectroscopy market growth is driven by increasing investments in pharmaceutical research, chemical analysis, and academic applications.Austin, April 18, ...

Bipartisan congressional commission introduces legislation to coordinate emerging biotechnology research and boost investment ...

DABA Biotech Limited is revolutionising the biotechnology sector by fostering innovation, boosting global competitiveness and ...

Explore your interests to define your educational experience. Are you ready? Our master's or doctorate program in forest molecular genetics and biotechnology focuses on researching functional genomics ...

Should the approach translate to humans, people with allergies may one day be able to take a vaccine that protects them from dangerous allergic reactions.

Researchers say findings provide compelling evidence underscoring the potential of electric-field molecular fingerprinting for minimally invasive disease detection.

Molecular Partners AG’s MOLN share price has surged by 5.04%, which has investors questioning if this is right time to sell.

School of Biotechnology, Jawaharlal Nehru University New Delhi -110067 has invited applications for the Summer School 2025 in ...